A Blood Glucose Monitor that Can Lower Blood Glucose
We know that the key to manage diabetes type 2 is to avoid the ups and downs characteristics of this health condition. And the way to avoid them is to have a good control of blood glucose which leads us to a good monitoring system. The following study shows how continuous monitoring could be a solution.
Major U.S. Study Reveals Real-Time Continuous Glucose Monitoring Improves Control of Type 2 Diabetes
Study Published Today in Diabetes Care Journal Shows Dexcom(TM) SEVEN(R) CGM Intervention Group With Significantly Better Glucose Control Than Self-Monitoring Blood Glucose Alone
SAN DIEGO, CA, Nov 22, 2011 (MARKETWIRE via COMTEX) — Dexcom, Inc. DXCM -0.43% — Real-time, continuous glucose monitoring (CGM) is effective in improving blood glucose control in people with Type 2 diabetes, reveals a study published online today in Diabetes Care, a leading journal on diabetes research and management.
This is the first time that real-time Continuous Glucose Monitoring (CGM) has been studied in a large U.S.-based, randomized-controlled trial in people with Type 2 diabetes. Most studies have demonstrated that real-time CGM is effective in patients with Type 1 diabetes, or patients using intensive insulin treatment of both basal and meal time insulin.
The 52-week randomized controlled study at Walter Reed Army Medical Center found that real-time CGM is significantly better at controlling blood glucose in people with Type 2 diabetes than the more traditional method of self-monitoring of blood sugar (SMBG) at meal times and bedtime.
The study examined 100 patients with Type 2 diabetes who were not on meal-time insulin, and were treating their diabetes with a variety of medications. Patients were randomized to either pre-meal/bedtime self-monitoring of blood glucose or to a Dexcom(TM) SEVEN(R) CGM in four cycles (two weeks on, one week off) for three months. The devices were then removed and all patients were observed for nine months while undergoing regular care from their usual provider.
To continue reading, click the next page below:







